Although, not generally recognized, current practices of dissolution testing seek to adjust experimental conditions to obtain desired or expected drug release/dissolution characteristics. The variations or adjustments in experimental conditions, which are commonly referred to as method development steps, often relate to choice of apparatuses, rpms or flow-rates, media (nature and volumes) etc. Thus, current practices defeat the purpose of dissolution testing which are, in fact, supposed to be conducted to evaluate or establish drug release characteristics of a product, in particular, at the method development stage.  In addition, most standards and requirements are based on this practice of selecting and setting experimental conditions rather than evaluating products. 

For appropriate dissolution testing, the tests are to be conducted using product independent and fixed experimental conditions. This will facilitate in finding the actual drug dissolution or release characteristics of a product or will help in knowing one’s product. If one keeps on changing the experimental conditions, one will never know the true (dissolution) characteristics of the products.

Donate

Your support is needed in providing free and unbiased scientific work. Please donate (any amount). Thanks


Archives
Links

PharmacoMechanics

This will close in 0 seconds